# Efficacy of Dapagliflozin Versus Metformin in Polycystic Ovary Syndrome

> **NCT06576375** · PHASE3 · RECRUITING · sponsor: **Future University in Egypt** · enrollment: 70 (estimated)

## Conditions studied

- Polycystic Ovary Syndrome

## Interventions

- **DRUG:** Dapagliflozin
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT06576375
- **Lead sponsor:** Future University in Egypt
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-02
- **Primary completion:** 2025-01
- **Final completion:** 2025-01
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2024-10-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06576375

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06576375, "Efficacy of Dapagliflozin Versus Metformin in Polycystic Ovary Syndrome". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06576375. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*